FAMILIES USA FOUNDATION INC

S. 4445Right to IVF ActThe legislation would establish a right to access IVF treatments and mandate that public and private insurance plans cover such treatments. TBD Keeping Obstetrics Local Act Aims to address a rising trend of rural hospitals and hospitals in underserved areas closing their labor and delivery units with significant consequences for expectant parents, families, and their local communities. HR 3305, S 1606The Black Maternal Health MomnibusThis bill directs multi-agency efforts to improve maternal health with a particular focus on racial and ethnic minority groups, veterans, and other vulnerable populations. S. 4338Pay PCPs Acta bill to task the Centers for Medicare & Medicaid Services (CMS) with establishing hybrid payments to reward primary care providers who provide the best care to their patients H.R. 5378Lower Costs, More Transparency Actprice in health care sector; transparency and honest billing; site neutrap payments for drug administration S.3548"Health Care Prices Revealed and Information to Consumers Explained Transparency Act "Legislation to require hospitals to post a machine-readable file of negotiated rates and requiring the actual cash price and not allowing providers to offer a median of the discounted cash prices for a service. S.1869SITE ActTo amend title XVIII of the Social Security Act and title XXVII of the Public Health Service Act to ensure fair billing practice for items and services furnished by off-campus hospital locations, to amend such title XVIII to provide for payments for graduate nursing education costs, and for other purposes.

TBD Keeping Kids Covered Act The Keep Kids Covered Act(attached) would require states to provide multi-year CE for children with Medicaid or CHIP coverage. This includes continuous coverage until age 6 (with the ability to transfer from CHIP to Medicaid if eligibility changes) and then a 24-month continuous coverage period for eligible children ages 6-18. The bill would also require the states to keep individuals informed of their health coverage during the CE period, and to keep up-to-date contact information. S. 3138Stabilize Medicaid and CHIP Coverage Act Provide 12-month CE for adults in Medicaid and CHIP

s.150Affordable Prescriptions for Patients Act of 2023To amend the Federal Trade Commission Act to prohibit product hopping, and for other purposes.

HR 5378Lower Costs, More Transparency Act- Legislation to codify and strengthen hospital price transparency and transparency in coverage rules; enact site neutral payments for drug administration services; enact honest billing reforms to ensure a unique NPI number is used when billing to Medicare or commercial insurers to ensure large hospital systems do not overcharge for the care they deliver in outpatient settings. IVF Protection Act Establishing a statutory right to access IVF for all Americans who need it to start or grow a family.

Legislation to ensure that anyone with a valid prescription is not denied or intimidated when requesting birth control or emergency contraception at pharmacies. Contraception is an essential part of reproductive health care and is a protected fundamental right in the United States. S.113Prescription Pricing for the People Act of 2023To require the Federal Trade Commission to study the role of intermediaries in the pharmaceutical supply chain and provide Congress with appropriate policy recommendations, and for other purposes. s.150Affordable Prescriptions for Patients Act of 2023To amend the Federal Trade Commission Act to prohibit product hopping, and for other purposes. S. 1067Ensuring Timely Access to Generics Act of 2023To amend the Federal Food, Drug, and Cosmetic Act with respect to citizen petitions. S.142Preserve Access to Affordable Generics and Biosimilars ActTo prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, and to prohibit biological product manufacturers from compensating biosimilar and interchangeable companies to delay the entry of biosimilar biological products and interchangeable biological products S.148Stop STALLING ActTo enable the Federal Trade Commission to deter filing of sham citizen petitions to cover an attempt to interfere with approval of a competing generic drug or biosimilar, to foster competition, and facilitate the efficient review of petitions filed in good faith to raise legitimate public health concerns, and for other purposes.